- Home
- BTMD
BTMD
Biote Corp.
as 06-13-2025 4:00pm EST
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 129.1M | IPO Year: | N/A |
| Target Price: | $8.00 | AVG Volume (30 days): | 131.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.60 | EPS Growth: | 201.68 |
| 52 Week Low/High: | $3.04 - $8.44 | Next Earning Date: | 08-07-2025 |
| Revenue: | $199,379,000 | Revenue Growth: | 6.44% |
| Revenue Growth (this year): | 5.87% | Revenue Growth (next year): | 8.59% |
Stock Insider Trading Activity of Biote Corp. (BTMD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Guines LLC | BTMD | 10% Owner | May 6 '25 | Buy | $3.31 | 447,714 | $1,461,372.93 | 4,622,748 | |
| Guines LLC | BTMD | 10% Owner | Apr 30 '25 | Buy | $3.30 | 1,933 | $6,371.17 | 4,622,748 | |
| Guines LLC | BTMD | 10% Owner | Apr 21 '25 | Buy | $3.27 | 8,801 | $28,781.91 | 4,622,748 | |
| Guines LLC | BTMD | 10% Owner | Apr 16 '25 | Buy | $3.29 | 7,874 | $25,906.27 | 4,622,748 | |
| Guines LLC | BTMD | 10% Owner | Apr 8 '25 | Buy | $3.21 | 48,439 | $155,387.68 | 4,622,748 | |
| Guines LLC | BTMD | 10% Owner | Apr 3 '25 | Buy | $3.21 | 74,440 | $237,405.51 | 4,622,748 | |
| Guines LLC | BTMD | 10% Owner | Mar 31 '25 | Buy | $3.32 | 106,000 | $351,920.00 | 4,622,748 | |
| HEYER ANDREW R | BTMD | Director | Mar 17 '25 | Buy | $3.95 | 75,000 | $296,042.50 | 1,523,513 | |
| Beer Marc D | BTMD | Director | Mar 17 '25 | Buy | $3.87 | 107,794 | $417,162.78 | 107,794 | |
| Cone Stephen Mark | BTMD | Director | Mar 17 '25 | Buy | $3.88 | 38,104 | $147,843.52 | 160,829 |
Latest Biote Corp. News
BTMD Breaking Stock News: Dive into BTMD Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
Biote Names Rich Barrera to Board of Directors
Simply Wall St.
a month ago
biote First Quarter 2025 Earnings: Beats Expectations
Simply Wall St.
a month ago
biote Corp. Just Recorded A 469% EPS Beat: Here's What Analysts Are Forecasting Next
GuruFocus.com
a month ago
Biote Corp (BTMD) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Restructuring ...
Zacks
a month ago
Biote Corp. (BTMD) Q1 Earnings and Revenues Surpass Estimates
Business Wire
a month ago
Biote Reports First Quarter 2025 Financial Results
Business Wire
2 months ago
Biote Schedules First Quarter 2025 Financial Results Release and Conference Call
Insider Monkey
2 months ago
biote Corp. (BTMD): Insider Were Buying In Q1 2025
Compare BTMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BTMD Biote Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.